Zusammenfassung
Die neuen Leitlinien der European Society of Cardiology (ESC) zur Herzschrittmacher- und Resynchronisationstherapie wurden im September zeitgleich mit den neuen Herzinsuffizienzleitlinien am ESC-Kongress vorgestellt. Das neue Dokument beinhaltet ausführliche Abschnitte von der Patientenevaluation und klinischen Beurteilung über die Implantation und die Minimierung von Komplikationen bis zur Nachsorge. Aktualisiert und ergänzt wurden die Leitlinien dabei insbesondere um das Vorgehen bei Reflexsynkopen, die Indikation nach Transkatheteraortenklappenimplantation (TAVI) sowie das perioperative Management. Die Indikationen zur kardialen Resynchronisationstherapie wurden mit den Herzinsuffizienzleitlinien abgeglichen. Neue physiologische Stimulationsformen sowie der kabellose Schrittmacher wurden in die Leitlinien aufgenommen.
Abstract
The new European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization therapy were presented together with the new ESC heart failure guidelines at the ESC congress in September. The new document includes detailed sections on patient evaluation and clinical assessment, implantation, minimizing complications and patient follow-up. The guidelines have been updated and expanded particularly on the approach to reflex syncope, the indications after transcatheter aortic valve implantation (TAVI) and the perioperative management. The indications for cardiac resynchronization therapy (CRT) are now in line with the simultaneously published ESC heart failure guidelines. New physiological forms of stimulation and leadless pacing are now included in the guidelines.
Literatur
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European society of cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). Eur Heart J 34:2281–2329
Glikson M, Nielsen JC, Kronborg MB et al (2021) 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the task force on cardiac pacing and cardiac resynchronization therapy of the European society of cardiology (ESC) with the special contribution of the European heart rhythm association (EHRA). Eur Heart J 42:3427–3520
Shen W‑K, Sheldon RS, Benditt DG et al (2017) 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Circulation 136:e60–e122
Jackson LR 2nd, Rathakrishnan B, Campbell K et al (2017) Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? Pacing Clin Electrophysiol 40:442–450
Chen YW, Bai R, Lin T et al (2014) Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol 37:403–411
Inada K, Yamane T, Tokutake K et al (2014) The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace 16:208–213
Baron-Esquivias G, Morillo CA, Moya-Mitjans A et al (2017) Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study. J Am Coll Cardiol 70:1720–1728
Brignole M, Russo V, Arabia F et al (2021) Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J 42:508–516
Mcdonagh TA, Metra M, Adamo M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 42:3599–3726
Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128
Mcmurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008
Mcmurray JJV, Packer M, Desai AS et al (2014) Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004
Kaye GC, Linker NJ, Marwick TH et al (2015) Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the protect-pace study. Eur Heart J 36:856–862
Leclercq C, Sadoul N, Mont L et al (2016) Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT study. Eur Heart J 37:473–483
Deshmukh P, Casavant DA, Romanyshyn M et al (2000) Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 101:869–877
Vijayaraman P, Dandamudi G, Zanon F et al (2018) Permanent his bundle pacing: recommendations from a multicenter his bundle pacing collaborative working group for standardization of definitions, implant measurements, and follow-up. Heart Rhythm 15:460–468
Ali N, Keene D, Arnold A et al (2018) His bundle pacing: a new frontier in the treatment of heart failure. Arrhythm Electrophysiol Rev 7:103–110
El-Chami MF, Al-Samadi F, Clementy N et al (2018) Updated performance of the micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm 15:1800–1807
Brodell GK, Cosgrove D, Schiavone W et al (1991) Cardiac rhythm and conduction disturbances in patients undergoing mitral valve surgery. Cleve Clin J Med 58:397–399
Chung MK (2000) Cardiac surgery: postoperative arrhythmias. Crit Care Med 28:N136–144
Jaeger FJ, Trohman RG, Brener S et al (1994) Permanent pacing following repeat cardiac valve surgery. Am J Cardiol 74:505–507
Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620
Gilard M, Eltchaninoff H, Iung B et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715
Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705
Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the edwards SAPIEN valve. Circulation 122:62–69
Lilly SM, Deshmukh AJ, Epstein AE et al (2020) 2020 ACC expert consensus decision pathway on management of conduction disturbances in patients undergoing transcatheter aortic valve replacement: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol 76:2391–2411
Rogers T, Devraj M, Thomaides A et al (2018) Utility of invasive electrophysiology studies in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. Am J Cardiol 121:1351–1357
Tovia-Brodie O, Ben-Haim Y, Joffe E et al (2017) The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. J Interv Card Electrophysiol 48:121–130
Burri H, Starck C, Auricchio A et al (2021) EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the heart rhythm society (HRS), the asia pacific heart rhythm society (APHRS), and the Latin-American heart rhythm society (LAHRS). Europace 23:983–1008
Udo EO, Zuithoff NP, van Hemel NM et al (2012) Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 9:728–735
Koneru JN, Jones PW, Hammill EF et al (2018) Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads. J Am Heart Assoc 7(10):e7691. https://doi.org/10.1161/JAHA.117.007691
Ellenbogen KA, Hellkamp AS, Wilkoff BL et al (2003) Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 92:740–741
Poole JE, Gleva MJ, Mela T et al (2010) Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 122:1553–1561
Darouiche RO, Wall MJ Jr., Itani KM et al (2010) Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362:18–26
Mimoz O, Lucet JC, Kerforne T et al (2015) Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077
Tarakji KG, Mittal S, Kennergren C et al (2019) Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 380:1895–1905
Essebag V, Verma A, Healey JS et al (2016) Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study. J Am Coll Cardiol 67:1300–1308
Higgins JV, Gard JJ, Sheldon SH et al (2014) Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol 37:1284–1290
Horwood L, Attili A, Luba F et al (2017) Magnetic resonance imaging in patients with cardiac implanted electronic devices: focus on contraindications to magnetic resonance imaging protocols. Europace 19:812–817
Padmanabhan D, Kella DK, Mehta R et al (2018) Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm 15:228–233
Vuorinen AM, Pakarinen S, Jaakkola I et al (2019) Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population. Acta Radiol 60:1414–1421
Zecchin M, Severgnini M, Fiorentino A et al (2018) Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). Int J Cardiol 255:175–183
Hurkmans CW, Knegjens JL, Oei BS et al (2012) Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol 7:198
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Vogler, A. Keelani, A. Traub und R.R. Tilz geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Vogler, J., Keelani, A., Traub, A. et al. ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie. Herz 47, 31–40 (2022). https://doi.org/10.1007/s00059-021-05089-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-021-05089-0